Drug Resistance Updates is a bimonthly publication that contains thought-provoking reviews on important developments in drug resistance in infectious disease and cancer as well as novel drugs and strategies to overcome drug resistance.

It covers both basic research and clinical aspects of drug resistance, and involves disciplines as diverse as molecular biology, biochemistry, cell biology, pharmacology, microbiology, preclinical therapeutics, oncology and clinical medicine.

Articles are written by leaders in the field, in response to an invitation from the Editors, and are peer-reviewed prior to publication. Articles are clear, readable, and up-to-date, suitable for a multidisciplinary readership and include schematic diagrams and other illustrations conveying the major points of the article. The goal is to highlight recent areas of growth and put them in perspective.

*Expert reviews in clinical and basic drug resistance research in oncology and infectious disease

*Describes emerging technologies and therapies, particularly those that overcome drug resistance

*Emphasises common themes in microbial and cancer research

《耐药性更新》是一份双月刊，其中包含关于传染病和癌症耐药性重要发展以及克服耐药性的新药和策略的发人深省的评论。

它涵盖了耐药性的基础研究和临床方面，涉及分子生物学、生物化学、细胞生物学、药理学、微生物学、临床前治疗学、肿瘤学和临床医学等多种学科。

文章由该领域的领导者应编辑的邀请撰写，并在发表前经过同行评审。文章清晰、易读、最新，适合多学科读者，并包括示意图和其他插图，传达文章的主要观点。目标是突出最近的增长领域并对其进行透视。

*肿瘤学和传染病临床和基础耐药性研究的专家评论

*描述新兴技术和疗法，特别是那些克服耐药性的技术和疗法

*强调微生物和癌症研究中的共同主题

该刊已被国际权威数据库SCIE收录，该刊致力于发表经过严格同行评审的高质量原创文章，反映医学-药学领域的新进展、新技术、新成果，促进该领域科研交流和科研成果转化。该刊2023年影响因子为15.8，平均审稿速度为 约稿?周期不定 ，近四年来没有被列入预警名单。如果您需要投稿发表服务及指导，可以联系我们的客服老师，我们专业专注服务期刊投稿协助10年，为您提供期刊投稿个性化定制服务，并且我们确保严格保密您的个人信息及稿件内容。